Active Shortage Injection Other
Hydroxocobalamin Injection · 676 days since initial FDA posting
Brand: CYANOKIT
FDA lists Hydroxocobalamin Injection as Active Shortage (BTG International Inc.).
Availability on file: Limited Availability
Hydroxocobalamin Injection: Active Shortage
Limited Availability Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Hydroxocobalamin Injection
- Manufacturer
- BTG International Inc.
- Dosage Form
- Injection
- Presentation
- Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11)
- Package NDC
- 50633-310-11
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- Nov 4, 2024
- Last Updated
- Oct 31, 2025
- Therapeutic Category
- Other
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage.
Nearby, Other Hydroxocobalamin Shortage Records
FDA reason on file: Cyanokit is available to order. General shortage guidance lives on the tracker hub.